Genomic & Biopharma News

World Hepatitis Summit 2017 calls for immediate action to tackle viral hepatitis
On the eve of the World Hepatitis Summit in Brazil, WHO reports increasing global momentum in the response to viral hepatitis. A record 3 million people were able to obtain treatment for hepatitis C over the past two years, and 2.8 million more people embarked on lifelong treatment for hepatitis B in 2016.
News Medical Life Sciences, 2017-11-01 10:14:14

Cleveland Clinic selects Paxman Scalp Cooling System as one of top medical innovations for 2018
Paxman Scalp Cooling System has been named as one of Cleveland Clinic’s Top 10 Medical Innovations of 2018. The list of up-and-coming technologies was selected by a panel of Cleveland Clinic physicians and scientists and was announced at a presentation at the 2017 Medical Innovation Summit.
News Medical Life Sciences, 2017-11-01 10:13:53

Avalon GloboCare Acquires Leading Beijing Exosome Technology Company
Avalon GloboCare Corp. a leading global developer of cell-based technologies, announced today that its majority-owned subsidiary GenExosome Technologies Inc. (GenExosome) acquired 100% of the outstanding capital stock of Beijing Jieteng (Beijing GenExosome) Biotech Co. Ltd. Concurrently, GenExosome entered into and closed an Asset Purchase Agreement with Dr. Yu Zhou, CEO of GenExosome Beijing, pursuant to ...
Exosome RNA Research & Industry News, 2017-11-01 09:00:43

RNA-Seq provides first evidence of chemopreventive effect of a low dose combination of aspirin and Curcumin C3 Complex
In an extensive efficacy and mechanistic study using transcriptomic analysis using RNA-seq published in the leading journal Biochemical Pharmacology, researchers provided the first evidence of chemopreventive effect of a low dose combination of aspirin and Sabinsa’s Curcumin C3 Complex®. Colorectal cancer (CRC) is one of the major causes of human mortality and morbidity. Colitis-accelerated colon cancer ...
Transcriptome Research & Industry News, 2017-11-01 09:00:28

Studies of individual lncRNAs using multiple experimental approaches can help reveal the richness and complexity of lncRNA function
During both development and adulthood, the human brain expresses many thousands of long noncoding RNAs (lncRNAs), and aberrant lncRNA expression has been associated with a wide range of neurological diseases. Although the biological significance of most lncRNAs remains to be discovered, it is now clear that certain lncRNAs carry out important functions in neurodevelopment, neural ...
lncRNA Research and Industry News, 2017-11-01 09:00:24

Opinion: How to Define Cell Type
Advances in single-cell technologies have revealed vast differences between cells once thought to be in the same category, calling into question how we define cell type in the first place.
The Scientist, 2017-11-01 09:00:00

Opinion: How to Define Cell Type
Advances in single-cell technologies have revealed vast differences between cells once thought to be in the same category, calling into question how we define cell type in the first place.
The Scientist, 2017-11-01 09:00:00

Double disappointment for AstraZeneca lung drug tralokinumab
After a failed trial in May, AstraZeneca hoped tralokinumab could pass subpopulation tests and make it to the finish line, but it wasn’t meant to be.
Fierce Biotech, 2017-11-01 08:49:35

Frazier Healthcare Partners hits $419M for early-stage biotech play
California investment firm Frazier Healthcare Partners has gone over its hard cap target of $400 million as it looks to inject cash into early life science work.
Fierce Biotech, 2017-11-01 08:08:32